Short Interest in Astrana Health, Inc. (NASDAQ:ASTH) Declines By 8.6%

Astrana Health, Inc. (NASDAQ:ASTH) was the recipient of a large decline in short interest during the month of January. As of January 15th, there was short interest totalling 1,490,000 shares, a decline of 8.6% from the December 31st total of 1,630,000 shares. Based on an average daily volume of 303,600 shares, the days-to-cover ratio is currently 4.9 days. Currently, 4.2% of the shares of the stock are short sold.

Analyst Ratings Changes

A number of equities research analysts have recently commented on ASTH shares. KeyCorp initiated coverage on shares of Astrana Health in a report on Friday, October 11th. They set a “sector weight” rating for the company. Truist Financial cut their price target on Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a report on Monday, January 13th. Macquarie raised Astrana Health to a “hold” rating in a research report on Monday, December 16th. TD Cowen began coverage on Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 target price for the company. Finally, Robert W. Baird raised their price target on Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. Two equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $63.67.

Institutional Investors Weigh In On Astrana Health

Institutional investors and hedge funds have recently modified their holdings of the stock. State Street Corp purchased a new position in Astrana Health in the 3rd quarter worth approximately $91,966,000. Geode Capital Management LLC acquired a new position in shares of Astrana Health during the third quarter worth $58,995,000. FMR LLC purchased a new position in shares of Astrana Health in the third quarter valued at $48,413,000. SteelPeak Wealth LLC acquired a new stake in Astrana Health during the 3rd quarter valued at $39,398,000. Finally, Loomis Sayles & Co. L P purchased a new stake in Astrana Health during the 3rd quarter worth $30,251,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Trading Up 0.4 %

ASTH traded up $0.14 on Monday, reaching $37.01. 71,167 shares of the company’s stock were exchanged, compared to its average volume of 377,685. The company has a market cap of $2.08 billion, a price-to-earnings ratio of 28.55, a PEG ratio of 1.42 and a beta of 1.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. Astrana Health has a twelve month low of $29.08 and a twelve month high of $63.20. The company’s 50 day moving average is $36.27 and its 200-day moving average is $46.31.

Astrana Health (NASDAQ:ASTH) last issued its earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting analysts’ consensus estimates of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business had revenue of $478.71 million for the quarter, compared to the consensus estimate of $462.01 million. During the same quarter last year, the firm posted $0.47 EPS. Equities analysts predict that Astrana Health will post 1.15 earnings per share for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.